HomeBotulinum Toxin Type ABotulinum Toxin Type A + Muscle Relaxants

Does Botulinum Toxin Type A Interact with Muscle Relaxants?

Botulinum Toxin Type A and Muscle Relaxants have a moderate drug interaction according to U.S. FDA drug labeling data. May potentiate JEUVEAU's effects. Close observation recommended during concomitant use. The mechanism involves interference with neuromuscular transmission. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Botulinum Toxin Type A Class
Acetylcholine Release Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Botulinum Toxin Type A and Muscle Relaxants occurs because interference with neuromuscular transmission. Clinically, this means may potentiate jeuveau's effects. close observation recommended during concomitant use. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Botulinum Toxin Type A and your doctor is considering prescribing Muscle Relaxants (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Botulinum Toxin Type A(Dysport)+💊 Muscle Relaxants

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Acetylcholine Release Inhibitor
Drug B class
Source
NLP:prabotulinum toxin type a

What this means in plain English

May potentiate JEUVEAU's effects. Close observation recommended during concomitant use.

What the FDA label says

"Interference with neuromuscular transmission"

📖 Source: NLP:prabotulinum toxin type a

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Botulinum Toxin Type A and Muscle Relaxants against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.